| Mycosis Culture Collection From Dermatological Isolated (NCT05482763) | University of Rome Tor Vergata | 2022-07-20 |
| Radiofrequency in Onychomycosis (NCT05390190) | Cairo University | 2022-07-01 |
| Lasers in Onychomycosis (NCT05415852) | Cairo University | 2022-06-25 |
| A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) (NCT05279846) | Moberg Pharma AB | 2022-05-09 |
| A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis (NCT05089409) | AmtixBio Co., Ltd. | 2022-03-04 |
| Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis (NCT05578950) | Combined Military Hospital Abbottabad | 2022-03-01 |
| An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection (NCT05202366) | CAGE Bio Inc. | 2022-02-08 |
| Human Factors Testing for OTC Use of the Erchonia® LunulaLaser (NCT05626270) | Erchonia Corporation | 2021-06-04 |
| Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus (NCT04993066) | Candela Corporation | 2020-11-12 |
| Alpha-bisabolol for Onychomycosis Treatment (NCT04940520) | Universidade do Vale do Sapucai | 2020-06-01 |
| Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population (NCT04327622) | LMC Diabetes & Endocrinology Ltd. | 2020-03-03 |
| Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis (NCT03814343) | Mahidol University | 2019-01-15 |
| Laser Treatment for Onychomycosis in Diabetes (NCT02019446) | BCDiabetes.Ca | 2018-07-01 |
| A Study of the Systemic Absorption of MOB015B (NCT03244280) | Moberg Pharma AB | 2017-12-16 |
| Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail) (NCT03216200) | DeviceFarm, Inc. | 2017-07-07 |
| Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients (NCT03168841) | Western University of Health Sciences | 2017-06-06 |
| Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis (NCT02961634) | MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA | 2017-04-01 |
| Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis (NCT02812771) | Bausch Health Americas, Inc. | 2016-08-04 |
| Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail (NCT02798380) | Hallux, Inc. | 2016-07-01 |
| Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study (NCT02933879) | Sun Pharmaceutical Industries, Inc. | 2016-03-21 |
| Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis (NCT02724384) | Moe Medical Devices | 2016-03-01 |
| An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents (NCT03405818) | Pfizer | 2015-10-22 |
| Study Evaluating the Effect of Jublia on Dermatophytomas (NCT03098615) | University of Alabama at Birmingham | 2015-09-01 |
| Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis (NCT02549001) | Polichem S.A. | 2015-08-20 |
| A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment (NCT02464826) | Mahidol University | 2015-07-01 |
| Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications (NCT01996995) | Medical Research Foundation, The Netherlands | 2015-03-01 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail (NCT02267356) | Viamet | 2015-02-17 |
| Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail. (NCT02355899) | photonamic GmbH & Co. KG | 2015-01-01 |
| Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail (NCT02343627) | Sun Pharmaceutical Industries, Inc. | 2014-12-01 |
| Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis (NCT02436291) | MB Mazor Ltd. | 2014-10-01 |
| Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population (NCT02547701) | Polichem S.A. | 2014-08-01 |
| Efficacy and Safety Study of ME1111 in Patients With Onychomycosis (NCT02022215) | Meiji Seika Pharma Co., Ltd. | 2013-12-19 |
| Chart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis (NCT02445495) | Jason K Rivers, MD, FRCPC, FAAD | 2013-11-01 |
| Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis (NCT01851590) | Helsinki University Central Hospital | 2013-10-01 |
| Pulsed Dye Laser Treatment of Onychomycosis (NCT01915355) | Thomas Jefferson University | 2013-07-01 |
| Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients (NCT01841996) | Meiji Seika Pharma Co., Ltd. | 2013-03-01 |
| Pilot Study to Evaluate Plasma Treatment of Onychomycosis (NCT01819051) | Moe Medical Devices | 2013-03-01 |
| Study of Erchonia Low Level Laser Light Therapy to Treat Toenail Fungus (NCT02242019) | Erchonia Corporation | 2013-02-01 |
| Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole (NCT01615913) | Taiwan Biotech Co., Ltd. | 2012-04-01 |
| Evaluation of an Oligonucleotide Array for Rapid Identification of Dermatophytes in Clinical Specimens (NCT02270697) | National Cheng-Kung University Hospital | 2012-03-01 |
| Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis (NCT01528813) | Brasilia University Hospital | 2012-02-01 |
| Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail (NCT01484145) | Nitric BioTherapeutics, Inc | 2011-12-01 |
| Diode Laser Treatment of Onychomycosis (NCT01452490) | ConBio, a Cynosure Company | 2011-10-01 |
| Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser (NCT01666002) | Stanford University | 2011-09-01 |
| Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail (NCT01400594) | Hisamitsu Pharmaceutical Co., Inc. | 2011-07-01 |
| Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus (NCT01534689) | Erchonia Corporation | 2011-04-01 |
| Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis (NCT01044381) | Topica Pharmaceuticals | 2010-12-01 |
| Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis (NCT01246518) | Moberg Pharma AB | 2010-12-01 |
| Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails (NCT01208129) | Promius Pharma, LLC | 2010-09-01 |
| Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails (NCT01208168) | Promius Pharma, LLC | 2010-09-01 |
| A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis (NCT01180491) | Moberg Pharma AB | 2010-09-01 |
| Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis (NCT01080079) | Nitric BioTherapeutics, Inc | 2010-05-01 |
| TDT 067 Onychomycosis Study (NCT01145807) | Celtic Pharma Development Services | 2010-04-01 |
| TDT 067 Open Label Multi-Dose Onychomycosis Study (NCT01790165) | Celtic Pharma Development Services | 2009-12-01 |
| A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule (NCT01039883) | Stiefel, a GSK Company | 2009-11-23 |
| Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis (NCT01008033) | Dow Pharmaceutical Sciences | 2009-11-01 |
| Effectiveness of Podiatry Care on Onychomycosis (EPOCAON) (NCT00938925) | University of Malaga | 2009-10-01 |
| A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus (NCT01014962) | Stiefel, a GSK Company | 2009-08-24 |
| Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis (NCT01014637) | Pierre Fabre Dermo Cosmetique | 2009-08-01 |
| Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis (NCT00941317) | Galderma R&D | 2009-07-01 |
| PinPointe FootLaser for the Treatment of Onychomycosis (NCT00935649) | PathoLase, Inc. | 2009-06-01 |
| Treating Onychomychosis (NCT00776464) | Nomir Medical Technologies | 2008-11-01 |
| Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis (NCT00791219) | Halcygen Pharmaceuticals Limited | 2008-11-01 |
| Efficacy and Safety of RV4104A Ointment in Onychomycosis (NCT00808366) | Pierre Fabre Dermo Cosmetique | 2008-10-01 |
| Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste (NCT00781820) | Bayer | 2008-10-01 |
| Anti-mold Azole in the Prophylaxis for Invasive Fusariosis (NCT02714504) | Universidade Federal do Rio de Janeiro | 2008-08-01 |
| Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis (NCT00730405) | Stiefel, a GSK Company | 2008-07-16 |
| Efficacy Study of LIQUICURE™ to Treat Toe Nail Fungus (NCT00960089) | Chesson Laboratory Associates, Inc | 2008-07-01 |
| A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis (NCT00777868) | Dow Pharmaceutical Sciences | 2007-10-01 |
| A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED) (NCT00491764) | Merck Sharp & Dohme LLC | 2007-06-01 |
| Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II) (NCT00679601) | Pfizer | 2007-03-31 |
| Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail (NCT01278394) | Pfizer | 2007-03-01 |
| Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis (NCT00459537) | Novartis | 2007-03-01 |
| Cumulative Irritation Test (NCT00680095) | Pfizer | 2007-01-22 |
| Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail (NCT00453271) | NanoBio Corporation | 2007-01-01 |
| Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail (NCT00443820) | Novartis Pharmaceuticals | 2006-12-01 |
| A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail (NCT00385502) | Abeona Therapeutics, Inc | 2006-09-01 |
| Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail. (NCT00356915) | Stiefel, a GSK Company | 2006-07-01 |
| Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis (NCT00680134) | Pfizer | 2006-06-30 |
| Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I) (NCT00680160) | Pfizer | 2006-04-30 |
| Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail (NCT00679523) | Pfizer | 2005-11-01 |
| Topical Gel Anti-Fungal Agent for Tinea Unguium (NCT00253305) | MediQuest Therapeutics | 2005-09-01 |
| Spread of Dermatophytes Among Families (NCT00233493) | University Hospitals Cleveland Medical Center | 2005-03-01 |
| Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions (NCT00602342) | Roxane Laboratories | 2004-03-01 |
| Bioequivalency Study of Terbinafine Tablets Under Fed Conditions (NCT00602251) | Roxane Laboratories | 2004-03-01 |
| Topical Penlac Nail Lacquer for Onychomycosis in Children (NCT01419847) | Rady Children's Hospital, San Diego | 2002-03-01 |